|By PR Newswire||
|February 28, 2014 02:45 AM EST||
UPPSALA, Sweden, February 28, 2014 /PRNewswire/ --
The Swedish pharmaceutical company Oasmia Pharmaceutical AB (publ) today announced that the U.S. Food and Drug Administration (FDA) has conditionally approved Paccal Vet® CA-1 (paclitaxel for injection), providing veterinary oncologists with a new treatment option in the battle with canine mammary carcinoma and squamous cell carcinoma.
Paccal Vet CA-1 is the first veterinary drug to utilize paclitaxel, one of the most frequently used chemotherapeutics for the treatment of a wide range of cancers in humans for the past 20 years. Oasmia has signed an agreement with the global pharmaceutical company Abbott which gives its Animal Health division the exclusive worldwide distribution rights to Paccal Vet CA-1, excluding Russia, Japan and the Commonwealth of Independent States (CIS).
"The conditional approval of Paccal Vet CA-1 is a big step forward for veterinary cancer treatment," commented Julian Aleksov, chief executive officer of Oasmia. "In addition, it confirms the potential of our unique patented drug delivery technology, XR-17 - a novel derivative of vitamin A that we will be using in clinical trials with our other compounds for a number of human and veterinary indications."
"Pets are living longer and owners increasingly desire a 'human level of care' for serious and chronic conditions," said Andrea Wainer, divisional vice president and general manager, Abbott Animal Health. "With the FDA conditional approval of Paccal Vet CA-1 we are able to offer veterinarians and pet owners a trusted cancer therapy used to treat millions of people each year."
Cancer accounts for nearly 50 percent of all deaths in dogs 10 years of age or older. It is the leading cause of canine disease-related deaths, with up to three million new cases diagnosed annually worldwide.
Canine squamous cell carcinoma, a type of skin cancer, is a malignant tumor of epidermal cells which is often developed in the oral and nasal cavities and on the paws. Light-skinned and short-haired dogs who spend a long time in the sunshine have a higher risk of squamous cell carcinoma.
Mammary tumors are the most common tumor in female dogs that have not been spayed, affecting one out of every four.
For more information, please contact:
Mikael Widell, Vice President Communications
E-mail: [email protected]
Successful digital transformation requires new organizational competencies and capabilities. Research tells us that the biggest impediment to successful transformation is human; consequently, the biggest enabler is a properly skilled and empowered workforce. In the digital age, new individual and collective competencies are required. In his session at 19th Cloud Expo, Bob Newhouse, CEO and founder of Agilitiv, drew together recent research and lessons learned from emerging and established compa...
Dec. 3, 2016 12:45 PM EST Reads: 723
When it comes to cloud computing, the ability to turn massive amounts of compute cores on and off on demand sounds attractive to IT staff, who need to manage peaks and valleys in user activity. With cloud bursting, the majority of the data can stay on premises while tapping into compute from public cloud providers, reducing risk and minimizing need to move large files. In his session at 18th Cloud Expo, Scott Jeschonek, Director of Product Management at Avere Systems, discussed the IT and busin...
Dec. 3, 2016 12:45 PM EST Reads: 3,753
Data is the fuel that drives the machine learning algorithmic engines and ultimately provides the business value. In his session at Cloud Expo, Ed Featherston, a director and senior enterprise architect at Collaborative Consulting, discussed the key considerations around quality, volume, timeliness, and pedigree that must be dealt with in order to properly fuel that engine.
Dec. 3, 2016 12:45 PM EST Reads: 1,938
Dec. 3, 2016 12:15 PM EST Reads: 1,486
Dec. 3, 2016 12:00 PM EST Reads: 926
Dec. 3, 2016 12:00 PM EST Reads: 722
Dec. 3, 2016 11:45 AM EST Reads: 673
Dec. 3, 2016 11:45 AM EST Reads: 442
Dec. 3, 2016 11:30 AM EST Reads: 2,065
Dec. 3, 2016 11:30 AM EST Reads: 821
Dec. 3, 2016 11:15 AM EST Reads: 1,624
Dec. 3, 2016 10:45 AM EST Reads: 791
Dec. 3, 2016 10:45 AM EST Reads: 2,137
Connected devices and the industrial internet are growing exponentially every year with Cisco expecting 50 billion devices to be in operation by 2020. In this period of growth, location-based insights are becoming invaluable to many businesses as they adopt new connected technologies. Knowing when and where these devices connect from is critical for a number of scenarios in supply chain management, disaster management, emergency response, M2M, location marketing and more. In his session at @Th...
Dec. 3, 2016 09:30 AM EST Reads: 3,926
"Dice has been around for the last 20 years. We have been helping tech professionals find new jobs and career opportunities," explained Manish Dixit, VP of Product and Engineering at Dice, in this SYS-CON.tv interview at 19th Cloud Expo, held November 1-3, 2016, at the Santa Clara Convention Center in Santa Clara, CA.
Dec. 3, 2016 09:30 AM EST Reads: 827